SOX2 and cancer: Enhanced expressions for cancer stem cell markers Sox2, POU5F1(Oct4), Nanog, ALDHA1 and CD133 were observed in dormant and reactivated cancer cells after treatment of cisplatin (Fig. 3C, D).